Researchclopedia

Research Researchers Institutions Topics Submit About

Command Palette

Search for a command to run...

Researchclopedia

Research Researchers Institutions About

© 2026 Researchclopedia. Powered by OpenAlex under CC0 license.

Bruno Sangro | Researchclopedia

Back to researchers

Bruno Sangro

Navarre Institute of Health Research ORCID

810

Works

48,477

Citations

95

h-index

315

i10-index

Research Topics

Hepatocellular Carcinoma Treatment and Prognosis Liver Disease Diagnosis and Treatment Cancer Immunotherapy and Biomarkers

Affiliations

University of Geneva2025–2025

Universidad San Pablo CEU2023–2023

University of Padua2021–2022

Inserm2006–2006

Bristol-Myers Squibb (Germany)2013–2013

Top Works

Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial

Anthony B. El-Khoueiry,Bruno Sangro,et al.

20174,261 citations

Liver Disease and Transplantation

Cholangiocarcinoma and Gallbladder Cancer Studies

BCLC strategy for prognosis prediction and treatment recommendation: The 2022 update

María Reig,Alejandro Forner,et al.

20213,961 citations

Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

Philip J. Johnson,Sarah Berhane,et al.

20142,681 citations

Hepatocellular carcinoma

Josep M. Llovet,Jessica Zucman‐Rossi,et al.

20162,623 citations

Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma

Ghassan K. Abou‐Alfa,George Lau,et al.

20221,338 citations

Advances in immunotherapy for hepatocellular carcinoma

Bruno Sangro,Pablo Sarobe,et al.

20211,302 citations

Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib

Thomas Yau,Yoon‐Koo Kang,et al.

20201,179 citations

Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up

Arndt Vogel,Andrés Cervantes,et al.

20181,048 citations

Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy

María Reig,Zoe Mariñó,et al.

20161,011 citations